BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16698950)

  • 1. Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy.
    Mhawech-Fauceglia P; Dulguerov P; Beck A; Bonet M; Allal AS
    J Clin Pathol; 2007 Feb; 60(2):185-9. PubMed ID: 16698950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear expression of onco-suppressors nm23-H1 and maspin are associated with lower recurrence rate in laryngeal carcinoma.
    Marioni G; Ottaviano G; de Filippis C; Fasanaro E; Randon B; Meneghesso S; Giacomelli L; Astolfi L; Blandamura S
    Am J Otolaryngol; 2019; 40(2):224-229. PubMed ID: 30683471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maspin and Nm23-H1 expression in colorectal cancer.
    Pasz-Walczak G; Salagacka A; Potemski P; Balcerczak E; Kordek R; Mirowski M
    Neoplasma; 2010; 57(2):95-101. PubMed ID: 20099971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
    Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
    Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment.
    Wang YF; Chang CJ; Chiu JH; Lin CP; Li WY; Chang SY; Chu PY; Tai SK; Chen YJ
    Oncotarget; 2014 Sep; 5(17):7392-405. PubMed ID: 25277180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
    Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.
    Pavelić K; Kapitanović S; Radosević S; Bura M; Seiwerth S; Pavelić LJ; Unusić J; Spaventi R
    J Mol Med (Berl); 2000; 78(2):111-8. PubMed ID: 10794547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis.
    Franz L; Tealdo G; Contro G; Bandolin L; Carraro V; Giacomelli L; Alessandrini L; Blandamura S; Marioni G
    Head Neck; 2020 Aug; 42(8):2129-2136. PubMed ID: 32212364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
    Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
    J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
    He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
    Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the tumour-suppressor maspin in temporal bone carcinoma.
    Marioni G; Zanoletti E; Stritoni P; Lionello M; Giacomelli L; Gianatti A; Cattaneo L; Blandamura S; Mazzoni A; Martini A
    Histopathology; 2013 Aug; 63(2):242-9. PubMed ID: 23730906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
    Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
    Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maspin expression in oral squamous cell carcinoma.
    Iezzi G; Piattelli A; Rubini C; Goteri G; Artese L; Perrotti V; Carinci F
    J Craniofac Surg; 2007 Sep; 18(5):1039-43. PubMed ID: 17912078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and anti-metastatic potential of nm 23/NDP kinase in human head and neck cancer cells].
    Miyazaki H
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):189-95. PubMed ID: 9711037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma.
    Schlecht NF; Brandwein-Gensler M; Smith RV; Kawachi N; Broughel D; Lin J; Keller CE; Reynolds PA; Gunn-Moore FJ; Harris T; Childs G; Belbin TJ; Prystowsky MB
    Head Neck Pathol; 2012 Jun; 6(2):232-43. PubMed ID: 22228071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Kawasaki M; Sakabe T; Kodani I; Umekita Y
    Anticancer Res; 2021 Sep; 41(9):4563-4570. PubMed ID: 34475084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maspin expression in stage I and II oral tongue squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Hirakawa N; Kumamoto Y; Kuratomi Y; Tomita K; Komiyama S
    Head Neck; 2001 Nov; 23(11):962-6. PubMed ID: 11754500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.